SYRESpyre Therapeutics, Inc.UptrendEarnings in 7 days
TodayUptrend
92.91+2.86% todayClose of Oct 26, 2026 · end-of-day snapshot
Not sure what's inside? Read a full TSLA analysis, currently free
Technical readingsFree
RangeboundSee the full setup read: unlock SYRE
Trend state Uptrend, stage 2 of 4, no damage flags raised (as of Oct 26, 2026)
Automated read
The moving-average structure shows no decisive trend in either direction: the mid-term picture reads as rangebound. RSI is currently 54.
Readings, end-of-day Oct 26, 2026
RSI (14)Neutral54.14
MACD / signalAbove signal line-0.20 / -1.60, favorable reading
SMA 50Price above90.97, favorable reading
SMA 200Price above71.58, favorable reading
EMA 20Price above87.15, favorable reading
ADX (14)Rangebound17.15
Show all 12 readings
+DI / −DI+DI leading27.88 / 25.28
ATR (14)5.6% of price — elevated daily swings5.22, flagged reading
Stochastic %KMid-range73.55
Bollinger bands (20)Inside bands75.50 – 96.36
ROC (10)Positive over 10 sessions5.41, favorable reading
Trend / momentum impulseTrend and momentum disagreeMixed
Full analysis
What unlocking SYRE reveals
Company & theme write-upWhat the company does, the themes it belongs to, and the tags that place it beside its peers.Generated on unlock
Signal historyEvery past volume signal measured forward from the day it fired.Generated on unlock
AI narrativeThe volume, technical and fundamental reads tied into one plain-language story.Generated on unlock
Catalysts & risksScheduled events set beside the risks the narrative flags, each paired to its figure.Generated on unlock
Accumulation readVolume measured against this stock's own baseline, broken down day by day.Generated on unlock
Generated on unlock: written when SYRE's analysis runs, rather than checked against its stored data now.
Every section above, argued on SYRE's own numbers, on one page.
See what SYRE costsNot sure what's inside? Read a full TSLA analysis, currently freeUnlock the full SYRE analysis
AI narrative, signals and history, social sentiment and the full fundamentals, refreshed each market day for 30 days.
- Unlocked in about 60 seconds
- No account needed
- Secure checkout via Stripe
Covering a bigger list? Get 15 for $49.00: one-time, 30 days for the whole pack, swaps included.
Free weekly sample report
Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.
Need the raw data?Get SYRE + ~23,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset Earnings
When does Spyre Therapeutics, Inc. report earnings?
Spyre Therapeutics, Inc. (SYRE) is scheduled to report earnings on Nov 3, 2026.
The date is confirmed rather than estimated, though companies do occasionally reschedule.
Data as of Oct 27, 2026
See who else reports soon$9.90one-time Unlock SYRE